SocraTec R&D engages very much in early phase trials – not only with healthy subjects but also with patients. Our CPU is very well equiped for such investigations and our excellent patient access allows realising quite a lot of projects in a mono-centre setting. However, we are also very committed to promoting clinical trials that are being conducted jointly in Germany and Eastern Europe, with the vision to combine excellent quality with high-level patient recruitment. Therefore, we are pleased to participate in this exciting clinical trial symposium, bringing together Eastern European authorities, researchers and clinics with the international research and generic pharmaceutical industry.